|
|
|
|
|
Condensed Consolidated Interim Cash flows for the period ended
September 30, 2024
|
|
|
|
|
|
|
Notes
|
Sep. 30,
2024
|
|
Sep. 30,
2023
|
|
|
|
|
|
Cash flow from operating activities
|
|
|
|
|
Profit before income tax from
continued operations
|
|
58,621,506
|
|
31,606,522
|
Profit (loss) from discontinued
operations
|
|
-
|
|
(49,699)
|
Adjustments to reconcile profits to net cash provided by
operating activities
|
|
|
|
|
Fixed assets depreciation
|
17
|
763,079
|
|
655,051
|
Impairment Release/charge for credit
losses (Loans and advances to customers and banks)
|
|
4,224,251
|
|
1,050,980
|
Other provisions
Release/charge
|
22
|
430,005
|
|
2,350,253
|
Impairment Release/charge for credit
losses (due from banks)
|
|
829
|
|
(47,249)
|
Impairment Release/charge for
credit losses (financial investments)
|
|
(480,077)
|
|
213,039
|
Impairment Release/charge for other
assets
|
|
(11,956)
|
|
14,347
|
Exchange revaluation differences for
financial assets at fair value through OCI and AC
|
|
(18,536,183)
|
|
(5,409,592)
|
Goodwill amortization
|
|
-
|
|
30,943
|
Intangible assets
amortization
|
|
-
|
|
24,188
|
Revaluation differences Impairment
charge for Financial Assets at Fair value through OCI
|
|
1,193,810
|
|
-
|
Revaluation differences Impairment
charge for Financial Assets at Amortized cost
|
|
107,207
|
|
-
|
Revaluation differences Impairment
charge for due from banks
|
|
1,308
|
|
-
|
Utilization of other
provisions
|
22
|
(9,196)
|
|
(1,608)
|
Exchange Revaluation differences of
other provisions
|
22
|
3,962,591
|
|
1,096,665
|
Profits/losses from selling property
and equipment
|
7
|
(2,254)
|
|
(194)
|
Profits/losses from selling
financial investments at fair value through OCI
|
14.1
|
(377,992)
|
|
(149,012)
|
Losses (Profits) from selling
investments in associates
|
|
-
|
|
(7,466)
|
Impairment (Released) charges of
investments in associates
|
|
-
|
|
(9,000)
|
Share based payments
|
|
804,345
|
|
608,250
|
Bank's share in the profits / losses
of associates
|
|
8,533
|
|
39,486
|
Operating profits before changes in operating assets and
liabilities
|
|
50,699,806
|
|
32,015,904
|
|
|
|
|
|
Net
decrease / increase in assets and liabilities
|
|
|
|
|
Due from banks
|
|
(14,547,420)
|
|
9,859,636
|
Financial assets at fair value
through P&L
|
|
(2,066,889)
|
|
-
|
Derivative financial
instruments
|
|
(225,875)
|
|
172,635
|
Loans and advances to banks and
customers
|
12 - 13
|
(75,774,541)
|
|
(27,548,758)
|
Other assets
|
|
(14,094,581)
|
|
(2,506,019)
|
Non current assets held for
sale
|
|
-
|
|
(214)
|
Due to banks
|
18
|
(8,658,023)
|
|
15,526,008
|
Due to customers
|
19
|
223,729,483
|
|
136,052,663
|
Current income tax obligations
paid
|
|
(2,938,397)
|
|
(2,546,958)
|
Non current liabilities held for
sale
|
|
1,327
|
|
933
|
Other liabilities
|
|
(5,488,554)
|
|
(3,890,097)
|
Net
cash generated from (used in) operating
activities
|
|
150,636,336
|
|
157,135,733
|
|
|
|
|
|
Cash flow from investing activities
|
|
|
|
|
Proceeds from sale of investments in
associates
|
|
11,956
|
|
2,119
|
Payments for purchases of property,
equipment and branches construction
|
|
(2,401,070)
|
|
(1,177,450)
|
Proceeds from selling property and
equipment
|
|
2,254
|
|
194
|
Proceeds from redemption of
financial assets at amortized cost
|
|
1,226,638
|
|
5,278,030
|
Payments for purchases of financial
assets at amortized cost
|
|
(106,105,142)
|
|
(9,334,085)
|
Payments for purchases of financial
assets at fair value through OCI
|
|
(22,138,419)
|
|
(64,860,157)
|
Proceeds from selling financial
assets at fair value through OCI
|
|
55,475,567
|
|
75,128,566
|
Payment for investment in
subsidiaries
|
|
-
|
|
(1,008,761)
|
Net
cash generated from (used in) investing
activities
|
|
(73,928,216)
|
|
4,028,456
|
|
Condensed Consolidated Interim Cash flows for the period ended
September 30, 2024 (Cont.)
|
|
|
|
|
|
|
|
Sep. 30,
2024
|
|
Sep. 30,
2023
|
|
|
|
|
|
Cash flow from financing activities
|
|
|
|
|
Other loans
|
|
7,840,786
|
|
2,408,739
|
Dividends paid
|
|
(5,116,159)
|
|
(3,594,747)
|
Issued debt instruments
|
|
1,738,393
|
|
615,227
|
Capital increase
|
|
236,570
|
|
369,876
|
Net
cash generated from (used in) financing
activities
|
|
4,699,590
|
|
(200,905)
|
|
|
|
|
|
Net (decrease) increase in cash and
cash equivalent during the period
|
|
81,407,710
|
|
160,963,284
|
Beginning balance of cash and cash
equivalent
|
|
234,317,913
|
|
92,969,526
|
Cash and cash equivalent at the end of the
period
|
|
315,725,623
|
|
253,932,810
|
|
|
|
|
|
Cash and cash equivalent comprise:
|
|
|
|
|
Cash and balances at the central
bank
|
9
|
94,568,773
|
|
59,950,223
|
Due from banks
|
|
305,240,021
|
|
276,845,003
|
Treasury bills and other
governmental notes
|
11
|
82,174,775
|
|
71,507,826
|
Obligatory reserve balance with
CBE
|
|
(76,360,420)
|
|
(52,963,236)
|
Due from banks with maturity more
than three months
|
|
(19,125,420)
|
|
(30,994,611)
|
Treasury bills and other
governmental notes with maturity more than three months
|
|
(70,772,106)
|
|
(70,412,395)
|
Total cash and cash equivalent
|
|
315,725,623
|
|
253,932,810
|